v3.25.2
Acquisition of Biostrand - Summary of Allocated Purchase Price (Detail) - BioStrand B.V. [Member]
$ in Thousands
Apr. 13, 2022
CAD ($)
Disclosure of detailed information about business combination [line items]  
Cash $ 4,985
Common shares of the Company 29,126
Fair value of consideration 34,111
Cash 36
Amounts receivable 80
Unbilled revenue 8
Equipment and right-of-use assets 247
Intellectual property (not deductible for tax purposes) 28,459
Proprietary processes (not deductible for tax purposes) 391
Goodwill (not deductible for tax purposes) 12,658
Accounts payable and accrued liabilities assumed (342)
Deferred revenue 9
Leases (223)
Deferred income tax liability (7,212)
Total net assets acquired and liabilities assumed $ 34,111